PeopleBio, Inc. (KOSDAQ:304840)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,620.00
+16.00 (1.00%)
At close: Oct 2, 2025
1.00%
Market Cap33.03B
Revenue (ttm)3.13B
Net Income (ttm)-9.10B
Shares Out21.17M
EPS (ttm)-418.99
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume99,896
Average Volume307,224
Open1,601.00
Previous Close1,604.00
Day's Range1,595.00 - 1,649.00
52-Week Range1,517.00 - 6,090.00
Beta0.50
RSI33.39
Earnings DateNov 14, 2025

About PeopleBio

PeopleBio, Inc., a biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. PeopleBio, Inc. was founded in 2002 and is based in Seongnam, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2002
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 304840
Full Company Profile

Financial Performance

In 2024, PeopleBio's revenue was 3.73 billion, a decrease of -16.20% compared to the previous year's 4.45 billion. Losses were -10.91 billion, -31.94% less than in 2023.

Financial Statements

News

There is no news available yet.